@article{8f5a2beb6a2a43128b9a50a24c95c86d,
title = "Effects of dalcetrapib in patients with a recent acute coronary syndrome",
abstract = "In observational analyses, higher levels of high-density lipoprotein (HDL) cholesterol have been associated with a lower risk of coronary heart disease events. However, whether raising HDL cholesterol levels therapeutically reduces cardiovascular risk remains uncertain. Inhibition of cholesteryl ester transfer protein (CETP) raises HDL cholesterol levels and might therefore improve cardiovascular outcomes.",
keywords = "Acute Coronary Syndrome, Aged, Anticholesteremic Agents, Apolipoproteins, Biological Markers, Blood Pressure, C-Reactive Protein, Cardiovascular Diseases, Cholesterol Ester Transfer Proteins, Cholesterol, HDL, Cholesterol, LDL, Female, Humans, Male, Middle Aged, Recurrence, Risk, Sulfhydryl Compounds, Triglycerides",
author = "Schwartz, {Gregory G} and Olsson, {Anders G} and Markus Abt and Ballantyne, {Christie M} and Barter, {Philip J} and Jochen Brumm and Chaitman, {Bernard R} and Holme, {Ingar M} and David Kallend and Leiter, {Lawrence A} and Eran Leitersdorf and McMurray, {John J V} and Hardi Mundl and Nicholls, {Stephen J} and Shah, {Prediman K} and Jean-Claude Tardif and Wright, {R Scott} and {dal-OUTCOMES Investigators}",
year = "2012",
month = nov,
day = "29",
doi = "10.1056/NEJMoa1206797",
language = "English",
volume = "367",
pages = "2089--99",
journal = "The New England journal of medicine",
issn = "0028-4793",
publisher = "Massachusetts Medical Society",
number = "22",
}